Persistent hyperkinetic movements after deep brain stimulation of the subthalamic nucleus for Parkinson's disease."

Stathis PG, Smpiliris ME, Sakas DE.

Clin Neurol Neurosurg. 2013 Aug;115(8):1493-5. doi: 10.1016/j.clineuro.2012.11.023. No abstract available.

Malignant arrhythmia as the first manifestation of Wolff-Parkinson-White syndrome: a case with minimal preexcitation on electrocardiography.

Gungor B, Alper AT.

West Indian Med J. 2013 Sep;62(7):672-4. doi: 10.7727/wimj.2012.084.

Effect of dual-task interference on the hand flexibility of patients with Parkinson's disease carrying the leucine-rich repeat kinase 2 gene mutation.

Zhou G, Yang S, Chen T, Chan P, DU Y.

Exp Ther Med. 2013 Dec;6(6):1469-1474.

Factors related to outcomes of subthalamic deep brain stimulation in Parkinson's disease.

Kim HY, Chang WS, Kang DW, Sohn YH, Lee MS, Chang JW.

J Korean Neurosurg Soc. 2013 Aug;54(2):118-24. doi: 10.3340/jkns.2013.54.2.118.

Alpha-synuclein post-translational modifications as potential biomarkers for Parkinson disease and other synucleinopathies.

Schmid AW, Fauvet B, Moniatte M, Lashuel HA.

Mol Cell Proteomics. 2013 Dec;12(12):3543-58. doi: 10.1074/mcp.R113.032730. Review.

Fibroblast growth factor 20 polymorphism in sporadic Parkinson's disease in Northern Han Chinese.

Xu X, Wang N, Xu H, Xie A, Jiang H, Xie J.

J Clin Neurosci. 2013 Nov;20(11):1588-90. doi: 10.1016/j.jocn.2013.02.023.

Diffusional kurtosis imaging of cingulate fibers in Parkinson disease: comparison with conventional diffusion tensor imaging.

Kamagata K, Tomiyama H, Motoi Y, Kano M, Abe O, Ito K, Shimoji K, Suzuki M, Hori M, Nakanishi A, Kuwatsuru R, Sasai K, Aoki S, Hattori N.

Magn Reson Imaging. 2013 Nov;31(9):1501-6. doi: 10.1016/j.mri.2013.06.009.

The Ca2+/Mn2+ ion-pump PMR1 links elevation of cytosolic Ca(2+) levels to α-synuclein toxicity in Parkinson's disease models.

Büttner S, Faes L, Reichelt WN, Broeskamp F, Habernig L, Benke S, Kourtis N, Ruli D, Carmona-Gutierrez D, Eisenberg T, D'hooge P, Ghillebert R, Franssens V, Harger A, Pieber TR, Freudenberger P, Kroem

Cell Death Differ. 2013 Mar;20(3):465-77. doi: 10.1038/cdd.2012.142.

Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population.

Nie K, Zhang Y, Gan R, Wang L, Zhao J, Huang Z, Tang H, Wang L.

Neurosci Lett. 2013 Apr 29;541:111-5. doi: 10.1016/j.neulet.2013.02.024.

Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations.

Puschmann A.

Parkinsonism Relat Disord. 2013 Apr;19(4):407-15. doi: 10.1016/j.parkreldis.2013.01.020. Review.

Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms.

Cersosimo MG, Raina GB, Pecci C, Pellene A, Calandra CR, Gutiérrez C, Micheli FE, Benarroch EE.

J Neurol. 2013 May;260(5):1332-8. doi: 10.1007/s00415-012-6801-2.

Antidepressants for depression in Parkinson's disease: systematic review and meta-analysis.

Rocha FL, Murad MG, Stumpf BP, Hara C, Fuzikawa C.

J Psychopharmacol. 2013 May;27(5):417-23. doi: 10.1177/0269881113478282. Review.

Colonic inflammation in Parkinson's disease.

Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, Coron E, Bruley des Varannes S, Naveilhan P, Nguyen JM, Neunlist M, Derkinderen P.

Neurobiol Dis. 2013 Feb;50:42-8. doi: 10.1016/j.nbd.2012.09.007.

A possible pathophysiological role of tyrosine hydroxylase in Parkinson's disease suggested by postmortem brain biochemistry: a contribution for the special 70th birthday symposium in honor of Prof. Peter Riederer.

Nakashima A, Ota A, Kaneko YS, Mori K, Nagasaki H, Nagatsu T.

J Neural Transm (Vienna). 2013 Jan;120(1):49-54. doi: 10.1007/s00702-012-0828-5. Review.

Reduction in Parkinson's disease therapy improved punding but not feeling of presence.

Aquino CC, Celso de Castro P, Doná F, Medeiros L, Silva SM, Borges V, Ferraz HB.

J Neuropsychiatry Clin Neurosci. 2013 Summer;25(3):E43-4. doi: 10.1176/appi.neuropsych.12070173. No abstract available.